Related Experiment Video
Updated: Jun 12, 2026
07:12
A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
Published on: April 11, 2025
Costs of vision impairment: present and future issues
1Director, Population Health Division, Centre for Eye Research Australia, University of Melbourne, Locked Bag 8, East Melbourne 8002, Australia; Program Director, Vision Co-operative Research Centre, Sydney, Australia. jillek@unimelb.edu.au.
Expert Review of Pharmacoeconomics & Outcomes Research
|June 10, 2010
Summary
Measuring the costs of vision impairment lacks a standard method. Comparing global and country-specific data reveals how healthcare systems impact direct and indirect costs, highlighting the value of vision loss prevention programs.
Area of Science:
- Public Health
- Health Economics
- Ophthalmology
Background:
- Standardized methods for calculating vision impairment costs are currently lacking.
- Global and country-specific estimates of vision impairment costs vary significantly.
- Healthcare system differences influence the proportion of direct and indirect costs.
Purpose of the Study:
- To review existing methods for estimating the economic burden of vision impairment.
- To compare cost data from global estimates and specific industrialized nations (Australia, USA).
- To emphasize the cost-effectiveness of vision loss prevention initiatives.
Main Methods:
- Review of global and national cost-of-illness studies for vision impairment.
- Comparative analysis of direct and indirect cost components across different healthcare systems.
- Discussion of cost-effectiveness analysis findings for vision prevention programs.
Main Results:
- No single standard methodology exists for measuring vision impairment costs.
- Significant variations in cost estimates exist between global data and country-specific analyses.
- Cost-effectiveness modeling demonstrates substantial benefits from programs preventing vision loss and blindness.
Conclusions:
- The economic impact of vision impairment is substantial but inconsistently measured.
- Healthcare system structures significantly affect the economic burden of vision impairment.
- Evidence supports increased investment in national programs like Vision 2020 to prevent vision loss.
Related Concept Videos
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:16Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:17Accessory Structures of the Eye
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...